ZIMMER BIOMET HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value of $114.40 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue · last filed 2026-02-20
- ZIMMER BIOMET HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2025 was $114.40, a 17.20% decline from fiscal 2024.
- ZIMMER BIOMET HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2024 was $138.16.
- ZIMMER BIOMET HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2022 was $157.22.
- ZIMMER BIOMET HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2020 was $132.42, a 15.54% increase from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 12 month |
|---|---|
| 2025-12-31 | $114.40 10-K · filed 2026-02-20 |
| 2024-12-31 | $138.16 10-K · filed 2025-02-25 |
| 2023-12-31 | $147.16 8-K · filed 2024-08-07 |
| 2022-12-31 | $157.22 10-K · filed 2023-02-24 |
| 2021-12-31 | $122.90 8-K · filed 2022-06-22 |
| 2020-12-31 | $132.42 10-K · filed 2021-02-22 |
| 2019-12-31 | $114.61 10-K · filed 2020-02-21 |
| 2018-12-31 | $110.28 10-K · filed 2019-02-26 |
| 2017-12-31 | $107.02 10-K · filed 2018-02-27 |
| 2016-12-31 | $88.49 10-K · filed 2017-03-01 |
| 2015-12-31 | $74.82 10-K · filed 2016-02-29 |
| 2014-12-31 | $72.54 10-K · filed 2015-02-23 |
| 2013-12-31 | $65.03 10-K · filed 2014-02-28 |
| 2012-12-31 | $64.58 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |